{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380021390740411148.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Haruka Hirose"}],"foaf:familyName":[{"@value":"Hirose"}],"foaf:givenName":[{"@value":"Haruka"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360021390740411264","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1016/j.canlet.2023.216116"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0304383523000678?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0304383523000678?httpAccept=text/plain"},{"@type":"PMID","@value":"36878307"}],"notation":[{"@value":"MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.canlet.2023.216116_KyCQbEprNyimpSqVdqclDlywnz8"},{"@type":"OPENAIRE","@value":"doi_dedup___::9af313d9cfa3d969df91c73f1042c72c_KyCQbEprNyimpSqVdqclDlywnz8"}]}